121
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Treatment inferred disease severity in Crohn's disease: Evidence for a European gradient of disease course

, MD, , , , , , , , , , , , , , , , , , , , , & show all
Pages 333-344 | Received 29 May 2006, Published online: 08 Jul 2009

References

  • Loftus EV, Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002; 16: 51–60
  • Wolters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades?. Aliment Pharmacol Ther 2004; 20: 483–96
  • Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995; 30: 699–706
  • Thirlby RC, Land JC, Fenster LF, Lonborg R. Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: a prospective study. Arch Surg 1998; 133: 826–32
  • Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol 2000; 95: 177–82
  • Lewis JD, Schwartz JS, Lichtenstein GR. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. Gastroenterology 2000; 118: 1018–24
  • Faubion WA, Jr, Loftus EV, Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255–60
  • Metge CJ, Blanchard JF, Peterson S, Bernstein CN. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Am J Gastroenterol 2001; 96: 3348–55
  • Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994; 35: 360–2
  • Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nietert PJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999; 117: 49–57
  • Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417–29
  • Sonnenberg A. Geographic variation in the incidence of and mortality from inflammatory bowel disease. Dis Colon Rectum 1986; 29: 854–61
  • Garland CF, Lilienfeld AM, Mendeloff AI, Markowitz JA, Terrell KB, Garland FC. Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States. Gastroenterology 1981; 81: 1115–24
  • Shivananda S, Lennard Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690–7
  • Stockbrugger R, Russel MG, Bv M, Shivananda S. EC-IBD: a European effort in inflammatory bowel disease. Eur J Int Med 2000; 11: 187–90
  • Lennard Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; Suppl 170:2–6; discussion 16–9.
  • European Commission, Fifth Framework shared cost action (QLG4-CT-2000-01414). 2001–2005.
  • Wolters FL, Zeijl GV, Wessels F, Limonard C, Russel MGVM, Stockbrügger RW. Internet-based data inclusion in a European epidemiological follow-up study of IBD patients: a description of methods used. World J Gastroenterol 2005; 11: 7152–58
  • Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, Riis L, et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut 2006; 55: 1124–30
  • Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, et al. Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 2006; 55: 510–8
  • Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8–15
  • Singer J, Willet JB. Extending the Cox regression model. Applied longitudinal data analysis. Modelling range event occurrence. Oxford University Press, New York 2003; 543–605
  • Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995; 51: 524–32
  • Cleves M. Analysis of multiple failure-time data with stata. Stat Tech Bull 1999;49:340–47
  • Steinhart AH, Girgrah N, McLeod RS. Reliability of a Crohn's disease clinical classification scheme based on disease behavior. Inflamm Bowel Dis 1998; 4: 228–34
  • Riis L, Munkholm P, Binder V, Candstat LT, Langholz E. Intra- and interobserver variation in the use of the Vienna classification of Crohn's disease. Inflamm Bowel Dis 2005; 11: 657–61
  • Lennard Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol 1997; 9: 353–9
  • Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006; 101: 1274–82
  • Fernandez E, Schiaffino A, Borras JM, Shafey O, Villalbi JR, La Vecchia C. Prevalence of cigarette smoking by birth cohort among males and females in Spain, 1910–1990. Eur J Cancer Prev 2003; 12: 57–62
  • Kemm JR. A birth cohort analysis of smoking by adults in Great Britain 1974–98. J Public Health Med 2001; 23: 306–11
  • Brenner H. A birth cohort analysis of the smoking epidemic in West Germany. J Epidemiol Community Health 1993; 47: 54–8
  • Colombo P, Scarpino V, Zuccaro P, Apolone G, Gallus S, La Vecchia C. Smoking in Italian women and men, 2001. Tumori 2002; 88: 10–2
  • Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005; 54: 1481–91
  • Elliott DE, Urban JJ, Argo CK, Weinstock JV. Does the failure to acquire helminthic parasites predispose to Crohn's disease?. Faseb J 2000; 14: 1848–55
  • Miura S, Tsuzuki Y, Hokari R, Ishii H. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease. J Gastroenterol Hepatol 1998; 13: 1183–90
  • Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992; 103: 954–60
  • Mayberry JF, Newcombe RG, Rhodes J. Mortality in Crohn's disease. Q J Med 1980; 49: 63–8
  • Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777–82
  • Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244–50
  • Polito JM, 2nd, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111: 580–6
  • Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 643–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.